Thermogenesis

Adhesives & Sealants

ThermoGenesis Announces Sale of CryoSeal® Product Line to Asahi

RANCHO CORDOVA, Calif. - ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, said today that Asahi Kasei Medical Co., Ltd., has exercised its option to purchase the Company's CryoSeal Fibrin Sealant System wound care product line for $2 million in cash, effective June 30, 2012. Payment is due during the...

Read More »
Laboratory and Research Supplies and Equipment

Automated Medical Device quickly processes bone marrow.

Able to processes bone marrow within 15 minutes, Res-Q(TM) 60 BMC System optimizes rate of stem cell recovery. Functionally closed system features 60 mL chamber and is specifically used for concentration of bone marrow-derived stem cells at point of care. Packaged for sterile field, system is and designed to provide high-quality cell concentrates from bone marrow aspirates for orthopedic...

Read More »
Agricultural & Farming Products

ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention

RANCHO CORDOVA, Calif., Dec. 10 -- ThermoGenesis Corp. (NASDAQ:KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that the Company has introduced a new line of veterinary point-of-care (POC) products under the Vantus brand. Unveiling of the first product, Res-Q60v ePRP, is taking place at this week's 54th Annual Convention of the...

Read More »
Machinery & Machining Tools

ThermoGenesis Corp. Submits 510(k) Application to FDA for AutoXpress(TM) Cord Blood Processing System

RANCHO CORDOVA, Calif., Feb. 8 /- ThermoGenesis Corp. (NASDAQ:KOOL) announced today that the Company has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for its AutoXpress System (AXP(TM)). The AXP automates the isolation and capture of stem cells from umbilical cord blood in a functionally closed system. GE...

Read More »
Adhesives & Sealants

ThermoGenesis Announces Sale of CryoSeal® Product Line to Asahi

RANCHO CORDOVA, Calif. - ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, said today that Asahi Kasei Medical Co., Ltd., has exercised its option to purchase the Company's CryoSeal Fibrin Sealant System wound care product line for $2 million in cash, effective June 30, 2012. Payment is due during the...

Read More »
Laboratory and Research Supplies and Equipment

Automated Medical Device quickly processes bone marrow.

Able to processes bone marrow within 15 minutes, Res-Q(TM) 60 BMC System optimizes rate of stem cell recovery. Functionally closed system features 60 mL chamber and is specifically used for concentration of bone marrow-derived stem cells at point of care. Packaged for sterile field, system is and designed to provide high-quality cell concentrates from bone marrow aspirates for orthopedic...

Read More »
Agricultural & Farming Products

ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention

RANCHO CORDOVA, Calif., Dec. 10 -- ThermoGenesis Corp. (NASDAQ:KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that the Company has introduced a new line of veterinary point-of-care (POC) products under the Vantus brand. Unveiling of the first product, Res-Q60v ePRP, is taking place at this week's 54th Annual Convention of the...

Read More »
Company News

ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement with UC Davis Center for Equine Health

COLLABORATION WILL FOCUS ON COLLECTION, PROCESSING AND STORAGE OF EQUINE CORD BLOOD, BONE MARROW AND PLACENTAL TISSUE STEM CELLS RANCHO CORDOVA, Calif., Feb. 27 -- ThermoGenesis Corp. (NASDAQ:KOOL), a leading supplier of innovative products and services that process and store adult stem cells, announced today that its wholly-owned subsidiary, Vantus, Inc., has signed a formal agreement with the...

Read More »
Company News

ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007

RANCHO CORDOVA, Calif., Sept. 19 / -- ThermoGenesis Corp. a leading supplier of innovative products and services that harvest, process, store, and administer therapeutic doses of adult stem cells for trea(TM)ent of disease and injury, announced today that Dr. William Osgood, the Company's Chief Executive Officer, and Mr. Matthew Plavan, Chief Financial Officer, will participate in the 2007 Global...

Read More »
Machinery & Machining Tools

ThermoGenesis Corp. Submits 510(k) Application to FDA for AutoXpress(TM) Cord Blood Processing System

RANCHO CORDOVA, Calif., Feb. 8 /- ThermoGenesis Corp. (NASDAQ:KOOL) announced today that the Company has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for its AutoXpress System (AXP(TM)). The AXP automates the isolation and capture of stem cells from umbilical cord blood in a functionally closed system. GE...

Read More »

All Topics